Etanercept and adalimumab in patients with RA and SpA in clinical practice: adverse events and other reasons leading to discontinuation of the treatment

  • T Läkinenpi (Contributor)
  • M Korpela (Contributor)
  • Vuolteenaho, K. (Contributor)
  • E Moilanen (Contributor)

    Activity: Talk or presentationConference presentation

    Description

    Contributors: Levälampi T, Korpela M, Vuolteenaho K, Moilanen E
    Period13 Mar 2008
    Event titleTampere Annual Postgraduate Medical Convention, March 13-15, 2008
    Event typeOther
    Degree of RecognitionNational